Background. Osteoprotegerin (OPG), an immunoregulatory member of the TNF receptor superfamily, is expressed in inflamed intestinal mucosa. We investigated whether OPG is produced by intestinal epithelial cells and tested the hypothesis that single-nucleotide polymorphisms (SNPs) in the gene encoding OPG (TNFRSF11B) are associated with traveler's diarrhea (TD) among North American travelers to Mexico.
Forty percent to 60% of travelers from industrialized nations suffer from traveler's diarrhea (TD) when visiting developing countries [1] . The majority of cases are due to enteropathogens that are endemic to the countries visited [2, 3] . Attack rates vary according to the region visited and season of travel. The main causal agents of TD are diarrheagenic Escherichia coli, with enterotoxigenic E. coli (ETEC) and enteroaggregative E. coli (EAEC) accounting for ϳ50% of all cases [3, 4] . Invasive bacterial pathogens-including other E. coli pathotypes and Shigella, Campylobacter, and Salmonella species-are responsible for 10%-25% of cases.
In addition to environmental risk factors, individual host genetics could influence susceptibility to TD. Recently, our group demonstrated associations between common polymorphisms in the interleukin (IL)-8 gene promoter as well as in exon 15 of the lactoferrin gene and infection due to bacterial enteropathogens in North American travelers to Mexico [5, 6] .
Osteoprotegerin (OPG) was identified a decade ago as a member of the tumor necrosis factor (TNF) receptor superfamily. OPG functions as a soluble receptor activator of NK-B ligand (RANKL) and TNF-related apoptosis-inducing ligand (TRAIL) [7] [8] [9] [10] . OPG lacks [8, 9] transmembrane and cytoplasmic domains and, when secreted as a mature protein of 308 aa, functions as a decoy receptor. OPG's ligand, TRAIL, and its receptors TRAIL-R1, -R2 and -R4 play vital roles in the regulation of inflammation in the gut [11, 12] and in determining T helper cell differentiation [11] [12] [13] . OPG also serves as an important mediator in bone physiology by blocking the effect of RANKL (expressed by activated cells, osteoblasts, and bone marrow cells) on osteoclasts activation [9, 14 -16] ; the RANKL/OPG system also regulates dendritic cell function [14, 16] , B cell maturation, and the development of efficient antibody responses [17] . OPG knockout mice develop severe osteoporosis [18, 19] , whereas overexpression of OPG in transgenic mice results in osteopetrosis [8] . The systemic administration of OPG results in an increase in bone mineral density and prevents ovariectomyinduced bone loss in rats [8] , and a single subcutaneous injection of OPG reduces bone resorption in postmenopausal women [20] .
The human OPG gene (TNFRSF11B) is a single-copy gene located on chromosome band 8q23-24 and is composed of 5 exons spanning 29 kb of the human genome [21] . A number of single-nucleotide polymorphisms (SNPs) in the OPG gene have been identified and found to be associated with bone mineral density [22] [23] [24] [25] , osteoporotic fractures [26] , and coronary artery disease [27] .
Human intestinal epithelial cell lines constitutively express OPG mRNA, secrete OPG, and express mRNA for RANKL. The expression of OPG is increased in inflamed human colonic epithelium, compared with that in healthy control subjects [28] . The RANKL/OPG system is activated in inflammatory bowel disease (IBD). Intestinal explant cultures obtained from patients with IBD release larger amounts of OPG than tissues from healthy control subjects or noninflammed segments obtained from patients with IBD [29] .
OPG is up-regulated during epithelial infection and during human experimental infection with Cryptosporidium oocysts [30] . Furthermore, pretreatment of epithelial cells with TRAIL has been shown to induce cell apoptosis and reduce parasite numbers [30] .
Because OPG is expressed in multiple tissues (including the gastrointestinal tract in response to Cryptosporidium) and because OPG production is determined by OPG polymorphisms, we sought to investigate (1) whether OPG is produced in vitro in response to infection with bacterial enteric pathogens, (2) whether intestinal OPG production increases in response to infection with agents of TD in humans, and (3) whether OPG polymorphisms known to be associated with decreased production of OPG are associated with the risk of acquiring TD.
METHODS

T84 cell culture and bacterial infection.
A human colonic epithelial cell line (T84) was used to study OPG production in vitro in response to enteric pathogens. T84 cells were seeded into 75-cm 2 tissue culture flasks and grown in Dulbecco's modified Eagle medium-F-12 medium (Cellgro) supplemented with 10% fetal bovine serum (Hyclone) and 1% antibiotic-antimycotic solution. Flasks were incubated at 37°C in a 5% CO 2 atmosphere. When the cell monolayer reached or neared confluence, cells were detached from the bottom of the flask by means of treatment with trypsin-EDTA and were split into a 12-well cell culture plate containing antibiotic-free medium. T84 cells were then infected at a bacteria-to-cell ratio of 100:1 with overnightgrown EAEC strain 042, enterohemorrhagic E. coli (EHEC) strain 91-8123, enteropathogenic E. coli (EPEC) strain E2348/ 69, and ETEC strain 115 in separate wells. E. coli HS (a commensal strain) and E. coli DH5␣ (a noninvasive and nontoxigenic strain) were included as nonpathogenic controls [31, 32] . Briefly, T84 cells were infected with the above-mentioned E. coli strains for 3 h at 37°C in a 5% CO 2 atmosphere. After 3 h at 37°C, serum-free supernatants were collected from each well, and human OPG was measured by ELISA as described below. Infection experiments were repeated 3 times with appropriate controls.
ELISA for OPG. Concentrations of human OPG in stool samples and cell culture supernatants were determined using a commercial sandwich ELISA kit (RayBiotech), in accordance with the manufacturer's instructions. Briefly, ϳ50 mg or 50 L of stool sample was diluted 5 times in dilution buffer, and 100 L of sample was added to individual wells in duplicate. A standard concentration curve was constructed using purified human OPG. After overnight incubation at 4°C, plates were washed with buffer, and fecal OPG concentration was determined using the standard curve.
ELISA for RANKL. Concentrations of human RANKL in fecal samples were determined using a commercial RANKL ELISA kit (BioVendor Laboratory Medicine), in accordance with the manufacturer's instruction. Briefly, ϳ50 mg or 50 L of stool sample was diluted 5 times in dilution buffer, and 100 L of the sample was loaded in duplicate onto each well. Plates were processed for ELISA after incubation at 4°C overnight. Recombinant human RANKL was used as standard, along with appropriate positive and negative controls. A standard normal curve was generated and used to relate optical density to concentration.
Human subjects. North American travelers 18 years old or those Ͼ16 years old for whom parental consent was granted attending summer language educational programs in Guadalajara and Cuernavaca, Mexico, during the summers of 2002-2006 were invited to participate in the study. Visitors were eligible to participate if they were otherwise in good health and had not traveled to an area of risk for TD within the preceding 6 months.
Visitors who had preexisting irritable bowel syndrome or known lactose intolerance; were taking any medications to prevent TD; had history of significant underlying enteric, pulmonary, cardiac, or renal disease; or used antacids, H 2 blockers, or proton pump inhibitors routinely were excluded from this study. Travelers completed a daily diary indicating the number and consistency of bowel movements and the presence of gastrointestinal symptoms, including abdominal pain, excess gas/bloating, nausea, vomiting, urgency, tenesmus, and fever. Participants were asked to report to a clinic on a weekly basis to exchange diaries if they remained healthy and to provide a stool sample for microbiological analysis if they became ill with TD. Treatment was given for diarrheal illness after stool samples were obtained for study. Subjects were followed-up prospectively in Mexico for up to 6 weeks. The presence of acute diarrhea was defined as the passage of 3 or more unformed stools within a 24-h period plus 1 or more symptoms supportive of enteric infection, including abdominal pain, cramping, excessive gas, nausea, vomiting, fever, urgency, bloody or mucus stool, and tenesmus. Written informed consent to participate in this study was obtained from all subjects. This study was approved by the University of Texas Health Science Center (Houston) Committee for the Protection of Human Subjects.
Microbiologic examination. Stool samples from subjects with diarrhea were collected and transported at 4°C directly or in Cary-Blair transport medium to the laboratory. An aliquot of stool was frozen for analysis of various markers. Fecal specimens were subjected to microbiologic analysis in our field laboratory in Mexico. Five individual E. coli-like colonies were stored until further processing. Stool samples were also examined for enteric protozoal parasites, including Giardia lamblia, Entamoeba histolytica, and Cryptosporidium species, by ELISAs (Alexon). Cultures for enteric bacteria were performed using 6 standard media: MacConkey, Tergitol, Hektoen enteric, Yersinia, TCBS (thiosulfate/citrate/bile salts/sucrose), and Campylobacter agar plates. The presence of diarrheagenic E. coli (EAEC, ETEC, EPEC, Shiga toxin-producing E. coli [STEC] , and enteroinvasive E. coli [EIEC] ) was detected by colony hybridization, as described elsewhere [33] , using colony polymerase chain reaction (PCR) or fecal PCR with specific primers for respective virulence markers (table 1) [34 -36] . Stool samples were evaluated for the presence of mucus, fecal leukocytes, and occult blood by conventional methods.
Genotyping. Human genomic DNA was extracted from peripheral blood leukocytes by means of a genomic DNA purification kit (Gentra System) or from human saliva by means of the Oragene DNA Purification Kit (DNA Genoteck). SNPs in the OPG gene were determined by means of the SNPlex Genotyping System (Applied Biosystems), using ϳ80 ng of DNA per the manufacturer's instructions. Four OPG SNPs were studied, including 1 at position Ϫ950 of the promoter region, 1 at position ϩ1181 in exon 1, and 2 in introns 2 and 4. GeneMapper software (version 4; Applied Biosystems), which assigns individual genotypes on the basis of the intensity and location of peaks, was used for analyzing the sequencing data and calling SNP genotypes.
Statistical analysis. Univariate and multivariate analyses were performed using the SPSS for Windows software package (version 15.0; SPSS). The association between OPG genotypes and outcome phenotypes (such as microbiological and clinical data) was assessed by 2 test or Fisher's exact test. In each case, the relative risks (RRs) and 95% confidence intervals (CIs) were calculated. Continuous variables were compared between case subjects and healthy control subjects by analysis of variance.
RESULTS
OPG production after in vitro infection.
The OPG concentrations found in culture supernatants of T84 cells infected or not infected with various E. coli strains are presented in figure 1. T84 cells infected with EAEC, EHEC, EPEC, or ETEC induced the production of significantly higher levels of OPG than did infection-free T84 cells (P Ͻ .05) (figure 1). OPG production did not increase in the supernatant of cells exposed to nonpathogenic E. coli strains HS and DH5␣.
Study population and risk factors for TD. Nine hundred sixty-eight travelers were included in this study. As shown in table 2, 68% of participants were female, 872 (90%) were white, 54 (6%) were African American, 23 (2%) were Asian, and 19 (2%) were of other races. The Hispanic ethnic group was composed of 112 (12%) subjects. Univariate analysis revealed that younger age, longer duration of stay, and travel during the summer season [37] had significant influences on rates of diarrhea (table 2) .
OPG SNPs and TD. Of the 4 SNPs examined, the SNP at position ϩ1181 (rs2073618) in the exon 1 region demonstrated a significant association with TD among North American travelers to Mexico (RR, 1.26 [95% CI, 1.09 -1.43]). This ϩ1181GϾC polymorphism results from a substitution that causes a corresponding amino acid change at codon 3 from lysine (AAG) to asparagine (AAC). In contrast, a SNP in the promoter region (OPG Ϫ950TϾC) and two SNPs in intronic regions were not associated with TD ( We then compared the distribution of genotypes for the SNP at position ϩ1181 among the various racial groups. Among white travelers, 25% were of the GG, 47% were of the GC, and 28% were of the CC genotype. In contrast, among African American visitors, 54% were of the GG, 41% of the GC, and 5% of the CC genotype (P Ͻ .001, for white compared with African American and all other racial groups).
Because the majority of our study participants (90%) were white and because the genotype distribution was influenced by race, we stratified our analysis and focused on the white participants to decrease genetic variability. Given the influence of length of stay and season of travel, we conducted a subgroup analysis that included white participants traveling for 7 days or more during the summer. In this subgroup analysis composed of 688 travelers, the distribution of the OPG ϩ1181 genotypes among TD cases was compared with the genotype distribution among healthy control subjects. As shown in table 4, the genotype distribution was significantly different. Further analysis demonstrated that travelers with the CC genotype were more likely to experience TD (23% vs. 32%; RR, 1.23 [95% CI, 1.06 -1.42]). This suggests that the influence of the OPG ϩ1181GϾC genotype follows a recessive model of inheritance. The genotype frequencies were in Hardy-Weinberg equilibrium (P Ͼ .05).
The potential associations between genotypes and agents of diarrhea are shown in table 5. The frequencies of the genotypes seen in subjects in whom a pathogen was identified were compared with the frequencies seen in the travelers who remained healthy. Of the 357 subjects who experienced TD, 255 (71%) visited the clinic and provided a stool sample for diagnostic testing. We identified a potential bacterial pathogen in 145 visitors (57%) who submitted a diarrheal stool sample. Of these visitors, an inflammatory pathogen (nonsecretory pathogens) was identified in 106 (42%) (table 5). At least 1 of the diarrheagenic E. coli pathotypes tested for was detected in a stool sample from 128 subjects (50%), EAEC was identified alone or with other agents in 93 (36%), and ETEC was identified in 82 (32%) and included heat-labile toxin-producing, heat-stable toxin-producing, and heat-labile/heat-stable toxin-producing strains. EPEC was found in the stool of 62 subjects (24%), whereas STEC was found in the stool of 18 (7%). In the case of EIEC, ial and ipaH genes were found by PCR in 13 stool samples (5%) (table 5) . Salmonella, Shigella, and Campylobacter organisms were found in stool samples from 8 subjects (3%), 3 subjects (1%), and 2 subjects (0.8%), respectively. Overall, subjects with the OPG ϩ1181 CC genotype were more likely to have inflammatory pathogens identified in their stool (RR, 1.85 [95% CI, 1.34 -2.54]), whereas no association was seen among the cases due to ETEC (table 5) .
OPG and intestinal inflammation. To study the impact of the OPG ϩ1181 SNP on intestinal inflammation, we compared frequencies of inflammatory markers in stool samples. We noted a significant difference in the distribution of the CC genotype among subjects with mucus identified in their stool samples, compared with that among healthy control subjects (26/ OPG in stool samples. We then measured the concentrations of OPG in stool samples from healthy control subjects and patients with diarrhea. Fecal OPG levels ranged from 8 to 1567 pg/mL for healthy visitors and from 8 to 4536 pg/mL for visitors with diarrhea. The mean OPG level among those with TD tended to be slightly higher, although not significantly so, than (27) 10 (31) 3 (33) 11 (18) 15 (20) GC (n ϭ 312) 168 (51) 144 (40) 13 (41) 5 (56) 23 (38) 29 (39) CC (n ϭ 193) 77 (23) 116 (32) 9 (28) 1 (11) 26 (43) 31 (41 (26) 22 (24) 24 (29) 13 (21) 6 (33) 4 (23) 26 (24) GC (n ϭ 312) 168 (51) 39 (42) 32 (39) 23 (37) 3 (17) 2 (15) 36 (34) CC (n ϭ 193) 77 (23) 32 (34) 26 (32) 26 (42) that in healthy subjects (mean Ϯ SD OPG level, 186.3 Ϯ 504.5 pg/mL for patients with TD vs. 121.1 Ϯ 351.1 pg/mL for healthy control subjects). Because we noticed a significant association between the OPG ϩ1181 SNP and clinical outcomes of TD, we sought to investigate the associations between genotypes and the level of fecal OPG among travelers with diarrhea. The concentration of fecal OPG was lower in visitors with the CC genotype than in those with the GG and GC genotypes, but the differences did not reach statistically significance ( figure 2A) . Similarly, no significant difference between the 3 genotypes was noted in the level of RANKL or in the ratio of OPG to RANKL ( figure 2B and 2C) .
DISCUSSION
In the present study, we found that a SNP located in exon 1 at position ϩ1181 of the OPG gene is associated with diarrhea due to nonsecretory enteropathogens in North American travelers to Mexico. We have now also demonstrated increased OPG secretion by T84 cells in response to enteric pathogenic but not to nonpathogenic E. coli. This is the first report of an association between OPG production in response to intestinal bacterial infection in humans as well as between OPG SNPs and diarrheal disease. Of interest, the ϩ1181 CC genotype was associated with E. coli pathotypes that traditionally have been associated with inflammatory diarrhea (EPEC, EHEC, and EIEC) rather than with pathotypes associated with toxin production (such as ETEC). We noted little correlation with diarrhea due to EAEC, an organism that has the ability to cause both a noninflammatory and an inflammatory response [4, 31] . The OPG ϩ1181 SNP results in a transition from lysine, a charged polar amino acid, to asparagine, an uncharged amino acid. This transition in the OPG signal peptide is thought to lead to decreased OPG secretion. Of interest, postmenopausal women with the OPG ϩ1181 CC genotype have lower serum levels of OPG and increased bone mineral density [38] . Similarly, we found that travelers with diarrhea who had the CC genotype (Asn-Asn) displayed a trend toward lower levels of fecal OPG than those among visitors with the GG and GC genotypes. This could indicate that a change of amino acid from lysine to asparagine may affect the kinetics of OPG secretion. Our study did not show an association between 3 OPG genotypes and concentrations of RANKL or the OPG/RANKL ratio, as has been shown in another study [38] . The variability in the range of fecal OPG levels seen in the present study could be due to a dilution effect from diarrhea, OPG degradation during transit through the gastrointestinal tract, or sample freezing and processing. It is also possible that multimer OPG was converted into monomeric OPG [39] , which are not measured equally by ELISA.
OPG acts as a decoy receptor for RANKL, inhibiting its binding to RANK and the binding of TRAIL to its receptors [15] . OPG is widely expressed in tissues, including human intestinal epithelial cells. Several intestinal epithelial cell lines constitutively express OPG mRNA and secrete OPG [28] , suggesting that OPG plays an important role in gut homeostasis and in the response to inflammation. Of interest, human milk contains OPG in concentrations that are 1000-fold higher than those found in normal human serum and could potentially play a role in neonatal intestine and developmental physiology [40] .
Serum OPG levels are increased in patients with Crohn disease and ulcerative colitis [29, 41, 42] . The high levels of serum OPG are thought to occur in response to IBD-induced osteoporosis. In the IL-2 knockout mouse colitis model, recombinant OPG modulates intestinal dendritic cell activity and reverses inflammation [43] .
OPG is regulated by inflammatory signals, including NF-B [44] . NF-B is activated in intestinal epithelial cells in response to a number of inflammatory responses, and it up-regulates OPG expression. OPG may, in turn, blunt the inflammatory ef- Figure 2 . Human osteoprotegerin (OPG) and receptor activator of NK-B ligand (RANKL) concentrations in fecal samples from travelers with the OPG ϩ1181GϾC single-nucleotide polymorphism (SNP). Data are presented as mean Ϯ SD picograms per milliliter for the GG (n ϭ 35), GC (n ϭ 46), and CC (n ϭ 27) genotype groups. A, Association between human fecal OPG levels and OPG ϩ1181GϾC SNP (rs2073618) genotypes. Fecal OPG levels were determined by a sandwich ELISA. B, Association between human fecal RANKL levels and OPGϩ1181GϾC SNP genotypes. Fecal RANKL were determined by a specific ELISA. C, OPG/RANKL ratios corresponding to study population genotypes.
fects of RANKL and TRAIL. It is plausible that low OPG levels might worsen the clinical presentation in patients exposed to invasive pathogens. On the basis of these observations, we hypothesize that OPG functions as an anti-inflammatory mediator in the gut that increases in response to intestinal infection. SNPs in the OPG gene that result in low production of OPG may lead to more-severe clinical manifestations in subjects infected with nonsecretory organisms.
There are several limitations to this study. First, all travelers with diarrhea did not provide stool samples for microbiological, OPG, and RANKL assays. Second, we did not include a control group to evaluate the role played by OPG/RANKL in response to asymptomatic colonization with pathogens to further confirm the association between the OPG ϩ1181GϾC SNP and symptomatic disease. Third, the exposure to diarrhea-causing agents may have not been uniform among participants, given that travelers report variable degrees of adherence to the avoidance of risky food items. There is also the potential for false associations due to multiple comparisons. Controversy exists as to the appropriateness of statistical adjustments (such as the Bonferroni correction) in this setting, which some find to be too conservative for an exploratory association study. Additional studies will be needed to confirm this observation in other populations.
In conclusion, our in vitro cell culture infection model suggests that OPG is secreted by intestinal epithelial cells in response to enteropathogens and that a SNP in exon 1 (OPG ϩ1181GϾC) of the OPG gene is associated with susceptibility to inflammatory diarrhea in North American travelers to Mexico. The study of the OPG gene and its SNPs may be of use in further understanding host susceptibility and the intestinal immune response to enteropathogens.
